Second Round of Abstract Submissions Closes on May 29, 2024

Important Dates

  • Second Round of Abstract Submissions Closes on
    May 29, 2024
  • First Call Registrations Closes on
    May 29, 2024
  • Final Call Registrations Closes on
    November 11, 2024

About Conference

Coalesce Research Group takes the immense Pleasure to invite all the Speakers, Delegates, Researchers, Students and Industrialists to join our “5th International Conference on Infection Prevention and Control”. It is a two-day conference going to be held from November 11-12, 2024 in Renaissance London Heathrow Hotel, London, UK.

The theme of the conference is “Infectious Diseases Prevention, Control and Cure”.

Infection Control 2024 will serve as a platform for Infectious Diseases Specialists, Infectious Diseases Researchers, Scientists, Faculties, Students, Business Professionals, Healthcare Professionals, Clinicians, Researchers, Academicians, Foundation Leaders, Infectious Diseases Associations and Societies, Medical Colleges, Pharmaceutical Companies and Industries, Medical Devices Manufacturing Companies, Drug Manufacturing Companies, Pharmaceutical Companies and Industries and others involved in this area to exchange and share their experiences and research results on all aspects of Infection Prevention and Control. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Infection Prevention and Control.

Infection control is required to prevent the transmission of communicable diseases in all health care settings. Infection control demands a basic understanding of the epidemiology of diseases, risk factors that increase patient susceptibility to infection, practices, procedures and treatments that may result in infections. The risk of acquiring a healthcare-associated infection is related to the mode of transmission of the infectious agent (e.g. CRE, CDI, MRSA, SSI, etc.) and the type of patient-care activity or procedure being performed and the underlying patient's host defenses.

When we look at the worldwide deaths due to Infectious Diseases the conference get significance on some diseases like Tetanus (500,000), measles (1 million), Malaria (2.1million), hepatitis b (1.1million), diarrhoea (3.1 million), tuberculosis (3.1 million), HIV/AIDS (1 million) and respiratory Infections (4.4 million).

Infection Control 2024 will focus on capturing new approaches and thinking, as well as the cornerstones of Infection Prevention and control with healthcare epidemiology, antimicrobial resistance and stewardship, IPC in long-term care and non-clinical settings, education, training, staff development, community engagement and patient care.

The conference will again offer a unique forum for participants to exchange knowledge and experience in the prevention of healthcare-associated infections and control of antimicrobial resistance around the world.

The most resonating topics will be addressed including: Infection Prevention in the context of the COVID-19 pandemic, antimicrobial resistance, catheter-related bloodstream infection, quality of patient care, advanced methods in hospital epidemiology research and early results of major clinical trials in the field, improving prevention strategies using various implementation tools as well as social media, telemedicine, and simulation models.

Why to attend?

Infection Control 2024 is giving a worldwide stage to analysts that afford new insights into the concealed methods of Infection Control and the recent pandemic diseases that can be covered. World-eminent speakers, guest of honours and the most up to date upgrades are particular components of this gathering and with individuals from around the globe concentrated on finding out about uncommon illnesses and its advances. An expanding number of distinguished methods makes it important to complete propelled research here of irresistible sicknesses on Infectious Diseases and Virology.

With members from all over the world concentrated on learning about global trends on emerging infectious diseases and it promotes in therapeutic and diagnostic market, this is your finest chance to reach the largest accumulation of participants from the Infectious diseases community. This particular conference Infection Control conduct presentations, distributes information, conducts meetings with current and prospective scientists, make a splash with new drug developments, and receive name recollection at this 2 days event. World distinguished speakers, the most recent therapeutic and diagnostic techniques, developments of Novel technologies and therapeutic measures for infectious diseases prevention and treatment are the authentication marks of this conference.

Target Audience

  • Infectious Diseases Specialists
  • Infectious Diseases Experts
  • Infection Prevention and Infection Control Specialists
  • Microbiologists
  • Virologists
  • Bacteriologists
  • Pathologists
  • Parasitologists
  • Mycologists
  • Immunologists
  • Epidemiologists
  • Allergists
  • Dermatologists
  • Neurologists
  • Pediatricians
  • Clinical Investigators
  • Physicians
  • Pharmacists
  • Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
  • Infectious Diseases Researchers, Scientists, Faculties, Students
  • Research Associates
  • Academic and Health Care Professionals
  • Infectious Diseases Associations and Societies
  • Health Care Associations and Societies
  • Medical Colleges and Training Institutes
  • Medical, Pharmacy Companies and Industries
  • Medical Devices and Drug Manufacturing Companies and Industries
  • Laboratory Technicians and Diagnostic Companies
  • Software Developing Companies
  • Data Management Companies
  • Business Entrepreneurs and Industrialists

aboutus-image

Organizing Committee

Renowned Speakers

Infection Control 2023

The 4th International Conference on Infection Prevention and Control was held on November 06-07, 2023 at City Seasons Suites, Dubai, UAE with the Theme: "Infectious Diseases Prevention, Control and Cure" and has witnessed an amalgamation of outstanding speakers who enlightened the attendees with their knowledge related to the field of Infectious Diseases Prevention and Control.

The conference hosted by Coalesce Research Group was marked with the attendance of renowned and brilliant researchers, business delegates and talented student communities representing more than 10 countries around the world.

The meeting was embarked with an opening ceremony followed by Keynote Sessions and followed by series of lectures (Oral & Posters) delivered by Honorable Guests and members of the Keynote forum. The highlights of the meeting were the eponymous lectures, delivered by

  • Gilbert Glady, European Bio Immune(G)ene Medicine Association (EBMA), France
  • Salah Eldin Hussein, Sheikh Khalifa Medical City, UAE
  • Christian Kanstrup Holm, UV Medico and Aarhus University, Denmark
  • Fatah Kashanchi, George Mason University, USA
  • Lequan Min, University of Science and Technology Beijing, China
  • Yoshimasa Yamamoto, Gifu University, Japan
  • Amine Si Ali, Centre Hospitalier Intercommunal de Cre´teil (CHIC), France
  • Yaeko Mitsumori, Osaka University, Japan
  • Samar M Solyman, Suez Canal University and Sinai University, Egypt
  • Sunil Palchaudhuri, Wayne State University School of Medicine, USA and Atlanta Health and Welfare Center for Women, India
  • Sereen MB Bataineh, Jordan University of Science & Technology, Jordan
  • Tatjana Meister, Dr.Meister OÜ, Estonia
  • Sergey Suchkov, Institute for Biotech & Global Health of Ros BioTech and A.I. Evdokimov MGMSU, Russia
  • Farwa Khizar and Hina Javaid, NMC Royal Hospital Sharjah, UAE
  • Filippo Castiglione, Biotechnology Research Center, UAE
  • Amirreza Sharif, Shahid Beheshti University, Iran
  • Franco Turani, Aurelia Hospital and European Hospital, Italy
  • Haifa M Al Naim, King Faisal University, KSA
  • Ikram Omar Osman, Laboratoire de Diagnostic Biologique, Djibouti
  • Mona Ali Al-bloushi, Ministry of Municipality, Qatar
  • Yehia S Mohamed, Ajman University, UAE
  • Sogand Aslani-Firouzabadi, Islamic Azad University, Iran
  • Oussaima El-dbouni, Aman Hospital, Qatar
  • Petra Borilova Linhartova, Masaryk University, Czech Republic
  • Afrah Aljohani, Umm Al-Qura University, KSA
  • Estephanie Padua, Sheikh Khalifa Specialty Hospital, UAE
  • Fawzia AJ Ramadan, Ministry of Municipality, Qatar
  • Hanan S Alghamdi, Umm Al-Qura University, KSA
  • Safae Tankiouine, University Sultan Moulay Slimane, Morocco
  • Manal Y Sameeh, Umm Al-Qura University, KSA
  • Uri Galili, Rush University Medical College, USA
  • Wenzyl Jean Etor, Victoriano Luna Medical Center, Philippines
  • Huang Wei Ling, Medical Acupuncture and Pain Management Clinic, Brazil
  • Sara Khalife, Beirut Arab University, Lebanon
  • Muhammad Mazhar, Guizhou University, China
  • Hafiza Farhat, Gomal University, Pakistan
  • Azuka Patrick Okwuraiwe, Nigerian Institute of Medical Research, Nigeria
  • Muhammad Ibrahim, Khyber Medical University, Pakistan
  • Samia Elzwi, University of Benghazi, Libya
  • Celia Schell, Centro Universitario de Estudios Microbiológicos y Parasitológicos (CUDEMyP), Argentina
  • Raju Ahmed, Jahangirnagar University, and Red Cross Red Crescent Climate Centre, Bangladesh
  • John N Kheir, Boston Children’s Hospital and Harvard Medical School, USA
  • Maxim Simonovsky, Soapy Care LTD, Israel and USA
  • Ingrid Eunice Salazar Briseño, Mexican Social Security Institute and Autonomous University of San Luis Potosi, Mexico
  • Outour T Alami, Umm Al-Qura University, KSA
  • Samaher A Al-Asiri, Umm Al-Qura University, KSA
  • Sahar Essa, Kuwait University, Kuwait
  • Manahil S Al-Harbi, Umm Al-Qura University, KSA
  • Essam Kotb, Imam Abdulrahman Bin Faisal University, KSA
  • Brandon Lucke-Wold, University of Florida, USA
  • Mohamed Adawee, University of Michigan, USA
  • Kimihiko Okazaki, Okazaki Medical Clinic, Japan

 

All of them provided their fruitful contributions in the form of highly informative presentations and made the conference a top notch one. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

With the grand success of Infection Control 2023, we are glad to announce our next upcoming conference “5th International Conference on Infection Prevention and Control” which is scheduled to be held on November 11-12, 2024 in London, UK.

Bookmark your dates…!!

Hoping to meet you again this coming year in London, UK!!!

 

Past Conference Gallery